Stock MRVI MARAVAI LIFESCIENCES HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Maravai LifeSciences Holdings, Inc.

Equities

MRVI

US56600D1072

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-03 EDT 		5-day change 1st Jan Change
8.97 USD +1.93% Intraday chart for Maravai LifeSciences Holdings, Inc. +16.49% +36.95%
04-18 Maravai LifeSciences Unit Opens New Manufacturing Facility in San Diego MT
04-10 Craig-Hallum Initiates Coverage on Maravai LifeSciences With Buy Rating, $15 Price Target MT

Business Summary

Maravai LifeSciences Holdings, Inc. is a life sciences company. The Company provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. The Company operates through two segments. Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acid products to support the needs of customer research, therapeutic and vaccine programs. The segment also provides research products for labeling and detecting proteins in cells and tissue samples. Biologics Safety Testing segment is focused on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities.

Number of employees: 650

Sales per Business

USD in Million2022Weight2023Weight Delta
Nucleic Acid Production
77.8 %
813 92.1 % 225 77.8 % -72.36%
Biologics Safety Testing
22.2 %
70 7.9 % 64 22.2 % -8.23%
Eliminations
0.0 %
0 0.0 % 0 0.0 % -57.14%

Sales per region

USD in Million2022Weight2023Weight Delta
North America
48.8 %
339 38.4 % 141 48.8 % -58.45%
Asia Pacific
33.7 %
110 12.4 % 97 33.7 % -11.25%
EMEA
17.3 %
433 49.0 % 50 17.3 % -88.47%
Latin and Central America
0.2 %
1 0.1 % 1 0.2 % -34.78%

Managers

Managers TitleAgeSince
William Martin CEO
 Chief Executive Officer 49 22-09-29
Carl Hull FOU
 Founder 66 14-02-28
Kevin Herde DFI
 Director of Finance/CFO 53 17-04-30
Mike Houston CTO
 Chief Tech/Sci/R&D Officer - -
Kate Broderick CTO
 Chief Tech/Sci/R&D Officer - 21-12-31
Peter Leddy ADM
 Chief Administrative Officer 59 22-06-26
Deb Hart IRC
 Investor Relations Contact - -
Christine Dolan PRN
 Corporate Officer/Principal 56 17-10-09
Kurt Oreshack LAW
 General Counsel 44 20-10-31

Members of the board

Members of the board TitleAgeSince
Dean Mihas BRD
 Director/Board Member 57 16-02-29
Sean Cunningham BRD
 Director/Board Member 48 16-02-29
Gregory Lucier BRD
 Director/Board Member 59 19-12-31
Susannah Gray BRD
 Director/Board Member 63 20-10-31
Carl Hull FOU
 Founder 66 14-02-28
John DeFord BRD
 Director/Board Member 62 23-07-19
Benjamin J. Daverman BRD
 Director/Board Member 46 16-02-29
Murali Prahalad BRD
 Director/Board Member 52 16-07-31
Jessica Hopfield BRD
 Director/Board Member 59 20-11-18
Anat Ashkenazi BRD
 Director/Board Member 51 20-11-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 119,094,026 0 0 42.84 %
Stock B 1 132,654,801 107,851,041 ( 81.30 %) 0

Shareholders

NameEquities%Valuation
GTCR LLC
16.39 %
21,681,033 16.39 % 188 M $
12 West Capital Management LP
8.770 %
11,602,988 8.770 % 101 M $
12 West Capital Management LP
8.770 %
11,602,988 8.770 % 101 M $
Vanguard Fiduciary Trust Co.
7.561 %
10,003,894 7.561 % 87 M $
Massachusetts Financial Services Co.
4.546 %
6,014,575 4.546 % 52 M $
BlackRock Advisors LLC
4.516 %
5,975,386 4.516 % 52 M $
Millennium Management LLC
4.374 %
5,786,849 4.374 % 50 M $
Mackenzie Financial Corp.
3.907 %
5,169,176 3.907 % 45 M $
Braidwell LP
3.810 %
5,040,635 3.810 % 44 M $
AQR Capital Management LLC
2.648 %
3,504,111 2.648 % 30 M $
NameEquities%Valuation
GTCR LLC
94.34 %
119,094,026 94.34 % 1 033 M $
NameEquities%Valuation
GTCR LLC
46.90 %
119,094,026 46.90 % 1 033 M $

Company contact information

Maravai Lifesciences Holdings, Inc.

10770 Wateridge Circle Suite 200

92121, San Diego

+

http://www.maravai.com
address Maravai LifeSciences Holdings, Inc.(MRVI)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Diagnostics & Testing

Sales per Business

Sales per region

Ratings for Maravai LifeSciences Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
8.97 USD
Average target price
9.785 USD
Spread / Average Target
+9.08%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

1st Jan change Capi.
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+36.95% 1.19B
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-16.10% 11.41B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
+67.65% 3.81B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-14.31% 2.16B
VERACYTE, INC. Stock Veracyte, Inc.
-26.03% 1.56B
SEEGENE, INC. Stock Seegene, Inc.
-2.40% 760M
CAREDX, INC Stock CareDx, Inc
-19.00% 506M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-38.57% 444M
CURIOX BIOSYSTEMS CO., LTD Stock Curiox Biosystems Co., Ltd
+13.72% 339M
HLB BIOSTEP CO.,LTD. Stock HLB bioStep Co.,Ltd.
+15.53% 227M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. MRVI Stock
  4. Company Maravai LifeSciences Holdings, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW